Expert Center for idiopathic recurrent pericarditis: First experience in Russia, realities and prospects
Introduction. Despite its status as an orphan disease, idiopathic recurrent pericarditis (IRP) represents a serious medical and social problem due to its predominantly affecting young, working-age individuals, frequent relapses, life quality decrease, and the risk of life-threatening complications.A.A. Safiullina, A.A. Petrukhina, R.R. Niyazov, I.V. Zhirov, Yu.F. Osmolovskaya, S.N. Tereshchenko, S.A. Boytsov
Objective: To evaluate the structure of visits, clinical and laboratory characteristics of IRP patients, and work output of IRP Expert center of Academician E.I. Chazov National Medical Research Center of Cardiology for 2024–2026.
Material and methods. A total of 116 visits to the Expert center during the outlined period were analyzed. Patient clinical and laboratory data, IRP treatment, and errors of the referral to a specialized facility were assessed.
Results. IRP was detected in 34 (29.3%) of 116 patients referred to the center. The range of other diagnoses included acute (22.4%) and chronic (42.3%) pericarditis, specific pericarditis (21.7%), including paraneoplastic (6.0%), tuberculous (5.2%), etc. Telemedicine consultations were provided to 55.2% of individuals. Among patients with IRP, females were prevailing (68%), the average age of patients was 44.0 ± 14.2 years, the median number of relapses was 3 [2; 5], the duration of the anamnesis was 13 [6; 18] months. Among the symptoms of IRP, chest pain (88.2%), pericardial effusion (56.0%), fever (65.0%) were predominant. Median C-reactive protein (CRP) level was 8.5 [2.0; 25.0] mg/L. Colchicine was administered to 91.2% of patients (intolerance was detected in 17.6%), and glucocorticosteroids to 50.0% (all of them demonstrated steroid dependence). Goflikicept was prescribed to 17 (50.0%) patients with IRP. The inflammatory phenotype of the disease (CRP >10 mg/L) was observed in 64.7%, while the non-inflammatory phenotype was present in 35.3% of patients with IRP. INFLA index estimation let us to reveale subclinical inflammation in 25% of patients with normal CRP. Frequent errors in referring patients to the Expert center included failure to exclude secondary causes of IRP (68.2%) and failure to complete the diagnostic checklist (52.9%).
Conclusion. The establishment of the Expert center has optimized the diagnosis, treatment, and accessibility of care for IRP. Phenotyping and INFLA index help identify hidden inflammation in certain category of patients. Creation and expansion of regional IRP centers network is a priority task to ensure accessibility to specialized care for patients with such kind of pathology.
Keywords
References
- Schulz-Menger J, Collini V, Groschel J, Adler Y, Brucato A, Christian V, et al.; ESC Scientific Document Group. 2025 ESC guidelines for the management of myocarditis and pericarditis. Eur Heart J. 2025;46(40):3952–4041.
PMID: 40878297. https://doi.org/10.1093/eurheartj/ehaf192
- Мячикова В.Ю., Маслянский А.Л., Моисеева О.М. Идиопатический рецидивирующий перикардит – новое орфанное аутовоспалительное заболевание? Ретроспективный анализ случаев идиопатического рецидивирующего перикардита и план рандомизированного, плацебо-контролируемого исследования для оценки терапевтической эффективности и безопасности блокатора ИЛ-1 (RPH-104). Кардиология. 2021;61(1):72–77. [Myachikova VYu, Maslyanskiy AL, Moiseeva OM. Idiopathic recurrent pericarditis – a new orphan autoinflammatory disease? A retrospective analysis of cases of idiopathic recurrent pericarditis and a design of а double-blind, randomized, placebo-controlled study to evaluate the efficacy and safety of RPH-104 treatment in patients with idiopathic recurrent pericarditis. Kardiologiya = Cardiology. 2021;61(1):72–77 (In Russ.)].
EDN: VTJRNU. https://doi.org/10.18087/cardio.2021.1.n1475
- Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: A systematic review. JAMA. 2015;314(14):1498–506.
PMID: 26461998. https://doi.org/10.1001/jama.2015.12763
- Klein AL, Abbara S, Agler DA, Appleton CP, Asher CR, Hoit B, et al. American Society of American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: Endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26(9):965–1012.e15.
PMID: 23998693. https://doi.org/10.1016/j.echo.2013.06.023
- Mascolo R, Wu MA, Berra S, Vidali M, Pancrazi M, Trotta L, et al. Recurrent pericarditis with normal C-reactive protein: Clinical and laboratory features, biomarkers and outcome in a non-inflammatory phenotype. Eur J Intern Med. 2025;135:108–17.
PMID: 40113467. https://doi.org/10.1016/j.ejim.2025.03.011
- Wang TKM, Klein AL, Cremer PC, Imazio M, Kohnstamm S, Luis SA, et al. 2025 Concise Clinical Guidance: An ACC Expert Consensus Statement on the diagnosis and management of pericarditis. J Am Coll Cardiol. 2025;86(25):2691–719.
PMID: 40767817. https://doi.org/10.1016/j.jacc.2025.05.023
- Петрухина А.А., Сафиуллина А.А., Осмоловская Ю.Ф., Жиров И.В., Стукалова О.В., Шитов В.Н., Терещенко С.Н. Побочные эффекты и неэффективность стандартной терапии идиопатического рецидивирующего перикардита: состояние проблемы и описание клинических случаев. Терапевтический архив. 2025;97(8):719–726. [Petrukhina AA, Safiullina AA, Osmolovskaya YuF, Zhirov IV, Stukalova OV, Shitov VN, Tereshchenko SN. Side effects and ineffectiveness of standard therapy for idiopathic recurrent pericarditis: State of the problem and description of clinical cases. Terapevticheskiy arkhiv = Therapeutic Archive. 2025;97(8):719–726 (In Russ.)].
EDN: NSBWRH. https://doi.org/10.26442/00403660.2025.08.203342
- Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M, et al. Effect of anakinra on recurrent pericarditis: The AIRTRIP randomized clinical trial. JAMA. 2016;316(18):1906–12.
PMID: 27825009. https://doi.org/10.1001/jama.2016.15826
- Imazio M, Andreis A, De Ferrari GM, Cremer PC, Mardigyan V, Maestroni S, et al. Anakinra for corticosteroid-dependent and colchicine-resistant recurrent pericarditis: The IRAP (International Registry of Anakinra for Pericarditis) study. Eur J Heart Fail. 2020;22(7):1204–12.
PMID: 31610707. https://doi.org/10.1177/2047487319879534
- Andreis A, Solano A, Balducci M, Picollo C, Ghigliotti M, Giordano M,et al. INFLA-score: A new diagnostic paradigm to identify pericarditis. Hellenic J Cardiol. 2025;84:43–50.
PMID: 38521501. https://doi.org/10.1016/j.hjc.2024.03.010.
- Арутюнов Г.П., Жиров И.В., Палеев Ф.Н., Айвазян С.А., Арутюнов А.Г., Васюк Ю.А. с соавт. Перикардиты. Клинические рекомендации 2025. Российский кардиологический журнал. 2026;31(6):129–193. [Arutyunov GP, Zhirov IV, Paleev FN, Ayvazyan SA, Arutyunov AG, Vasyuk YuA, et al. Pericarditis. Clinical guidelines 2025. Rossiyskiy kardiologicheskiy zhurnal = Russian Journal of Cardiology. 2026;31(6):129–193 (In Russ.)].
EDN: QLYSGV. https://doi.org/10.15829/1560-4071-2026-6671
- Сафиуллина А.А., Петрухина А.А., Осмоловская Ю.Ф., Жиров И.В., Терещенко С.Н. Идиопатический рецидивирующий перикардит: вчера, сегодня, завтра. Терапевтический архив. 2025;97(12):965–972. [Safiullina AA, Petrukhina AA, Osmolovskaya YuF, Zhirov IV, Tereshchenko SN. Idiopathic recurrent pericarditis: Yesterday, today, tomorrow. Terapevticheskiy arkhiv = Therapeutic Archive. 2025;97(12):965–972 (In Russ.)].
EDN: TUXJEO. https://doi.org/10.26442/00403660.2025.12.203447
- Ehsan M, Syed AB, Mustafa B, Ikram J, Khan MH, Cremer PC, et al. Comparative efficacy and safety of colchicine and anti-interleukin-1 agents in recurrent pericarditis: A pairwise and network meta-analysis. J Am Heart Assoc. 2025;14(13):e041007.
PMID: 40551317. https://doi.org/10.1161/JAHA.125.041007
- Raisinghani AB, Luis SA. Treatment options to break the cycle of recurrent pericarditis. Curr Opin Cardiol. 2025;40(2):107–14.
PMID: 39791409. https://doi.org/10.1097/HCO.0000000000001201
- Vecchie A, Bonaventura A, Golino M, Thomas G, Abbate A. Novel therapeutic insights into the treatment of pericarditis: Targeting the innate immune system. J Cardiovasc Pharmacol. 2024;83(5):377–83.
PMID: 38422218. https://doi.org/10.1097/FJC.0000000000001553
- Cremer PC, Luis SA, Garshick MS, Raisinghani A, Weber B, Winnowski D, et al.; RESONANCE Study GroupA. IL-1 pathway inhibition in recurrent pericarditis management: Real-world adoption of corticosteroid sparing in RESONANCE. JACC Adv. 2025;4(9):102050.
PMID: 40818264. https://doi.org/10.1016/j.jacadv.2025.102050
About the Authors
Alfiya A. Safiullina, MD, Dr. Sci. (Medicine), senior researcher at the Department of myocardial diseases and heart failure, Academician E.I. Chazov National Medical Research Center of Cardiology, Moscow, Russian Federation.E-mail: a_safiulina@mail.ru
ORCID: https://orcid.org/0000-0003-3483-4698. Scopus ID: 55540123600. eLibrary SPIN: 7118-1198
Angelina A. Petrukhina, MD, PhD (Medicine), junior researcher at the Department of myocardial diseases and heart failure, Academician E.I. Chazov National Medical Research Center of Cardiology, Moscow, Russian Federation.
E-mail: angelina-heart@yandex.ru
ORCID: https://orcid.org/0000-0002-4570-3258. Scopus ID: 54910214000.
Rena R. Niyazov, MD, applicant at the Department of myocardial diseases and heart failure, Academician E.I. Chazov National Medical Research Center of Cardiology; therapist at the Clinic of Early Rehabilitation, Regional Center “Three sisters” LLC, Moscow Region, Losino-Petrovsky city, Raiki Village.
E-mail: niyazovrr@yandex.ru
ORCID: https://orcid.org/0009-0002-8943-0447. eLibrary SPIN: 8200-7211
Igor V. Zhirov, MD, Dr. Sci. (Medicine), professor, leading researcher at the Department of myocardial diseases and heart failure, Academician E.I. Chazov National Medical Research Center of Cardiology, Moscow, Russian Federation.
E-mail: izhirov@mail.ru
ORCID: https://orcid.org/0000-0002-4066-2661. Scopus ID: 14625776600. eLibrary SPIN: 7704-3153.
Yulia F. Osmolovskaya, MD, PhD (Medicine), head of the Cardiology Department for myocardial diseases and heart failure, Academician E.I. Chazov National Medical Research Center of Cardiology, Moscow, Russian Federation.
E-mail: yuliaosm@mail.ru
ORCID: https://orcid.org/0000-0002-7827-2618. Scopus ID: 55672087300. eLibrary SPIN: 3638-7077.
Sergey N. Tereshchenko, MD, Dr. Sci. (Medicine), professor, head of the Department of myocardial diseases and heart failure, Academician E.I. Chazov National Medical Research Center of Cardiology, Moscow, Russian Federation.
E-mail: stereschenko@yandex.ru
ORCID: https://orcid.org/0000-0001-9234-6129. Scopus ID: 7006602366. eLibrary SPIN: 9556-2575.
Sergey A. Boytsov, MD, Dr. Sci. (Medicine), professor, academician of RAS, director general of Academician E.I. Chazov National Medical Research Center of Cardiology; chief external cardiology specialist of the Ministry of Healthcare of Russia for the Central, Ural, Siberian, and Far Eastern Federal Districts, Moscow, Russian Federation.
E-mail: prof.boytsov@gmail.com
ORCID: https://orcid.org/0000-0001-6998-8406. Scopus ID: 56580221300. eLibrary SPIN: 7961-5520



